PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- John Muir Physician Network Clinical Research Center
Concord, California, United States
- Amcr Institute Inc.
Escondido, California, United States
- Diablo Clinical Research
Walnut Creek, California, United States
- Barbara Davis Center for Diabetes
Aurora, Colorado, United States
- Atlanta Diabetes Care
Atlanta, Georgia, United States
- Rocky Mountain Diabetes Center C/o Research Department
Idaho Falls, Idaho, United States
- Clinical Trials of Texas
San Antonio, Texas, United States
- Rainier Clinical Research Center
Renton, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Dec 2018
- Primary completion
- 8 May 2020
- Completion
- 8 May 2020
- Last update posted
- 20 Aug 2024
- Registered enrollment
- 208
- Registry id
- NCT03808376
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.